Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16085581 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET
Condition: Coronary Artery Disease
Interventions: Drug: Exercise plus Regadenoson (Lexercise);   Drug: Regadenoson (Lexiscan)

Indicates status has not been verified in more than two years